Education
About Us
Working with TipRanks
Follow Us
Revolution Medicines (RVMD)
NASDAQ:RVMD
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 11.58M | $ 35.38M | $ 29.39M | $ 42.98M |
| Gross Profit | $ 0.00 | $ 11.58M | $ 25.72M | $ 22.06M | $ -89.27M |
| Operating Income | $ -689.52M | $ -487.19M | $ -258.28M | $ -188.01M | $ -110.70M |
| EBITDA | $ -689.52M | $ -430.58M | $ -239.47M | $ -179.75M | $ -101.91M |
| Net Income | $ -600.09M | $ -436.37M | $ -248.71M | $ -179.77M | $ -108.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.29B | $ 1.85B | $ 644.94M | $ 577.05M | $ 440.74M |
| Total Assets | $ 2.56B | $ 2.06B | $ 811.93M | $ 737.99M | $ 567.40M |
| Total Debt | $ 135.84M | $ 87.94M | $ 64.20M | $ 66.63M | $ 32.66M |
| Net Debt | $ -407.22M | $ -608.20M | $ -97.21M | $ -41.86M | $ -71.60M |
| Total Liabilities | $ 293.10M | $ 235.51M | $ 126.74M | $ 135.42M | $ 92.72M |
| Stockholders' Equity | $ 2.27B | $ 1.83B | $ 685.19M | $ 602.57M | $ 474.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -567.74M | $ -358.30M | $ -235.22M | $ -153.71M | $ -103.00M |
| Operating Cash Flow | $ -557.44M | $ -350.57M | $ -224.40M | $ -147.18M | $ -100.06M |
| Investing Cash Flow | $ -554.39M | $ -342.60M | $ -24.12M | $ -142.12M | $ -234.23M |
| Financing Cash Flow | $ 959.41M | $ 1.23B | $ 301.43M | $ 294.18M | $ 422.78M |